Subscribe To
CELL / PhenomeX to Report First Quarter 2023 Financial Results on May 11, 2023
CELL News
By Zacks Investment Research
May 11, 2023
PhenomeX Inc. (CELL) Reports Q1 Loss, Lags Revenue Estimates
PhenomeX Inc. (CELL) came out with a quarterly loss of $0.30 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss o more_horizontal
By PRNewsWire
April 27, 2023
PhenomeX to Report First Quarter 2023 Financial Results on May 11, 2023
EMERYVILLE, Calif. , April 27, 2023 /PRNewswire/ -- PhenomeX Inc. (Nasdaq: CELL), the functional cell biology company, today announced that the Compan more_horizontal